Dave is the CEO and Chief Scientific Officer of BioPhy, a healthcare fintech company committed to enhancing outcomes for patients and creating value for investors using their proprietary AI technology.
Prior to starting BioPhy with his co-founders at the The Wharton School at the University of Pennsylvania where he received his MBA, Dave was a Senior Scientist in the Advanced Analytics and Technology group at Johnson and Johnson.
Dave earned a PhD. in Chemical and Biomolecular Engineering from North Carolina State University.

In this episode we had the pleasure to hear about how his experience in Industry and MBA changed his perspectives, and inspired him to start BioPhy to challenge inefficiencies in the Healthcare system, mainly in clinical trial outcomes.
Join us to learn how engineering, finance and medicine found each other, and together created this exciting Healthcare fintech company.

BioPhy Website

Hosted by Jenna Glatzer and Joe Varriale